Cargando…

Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis

BACKGROUND: Sarcoidosis is a granulomatous disease, the etiology of which is currently unknown. The role of mycobacteria in the etiology of sarcoidosis has been extensively investigated. In this meta-analysis, we assessed the immunological evidence of the possible role of mycobacteria in the pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chuling, Huang, Hui, Xu, Zuojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968811/
https://www.ncbi.nlm.nih.gov/pubmed/27479700
http://dx.doi.org/10.1371/journal.pone.0154716
_version_ 1782445708820873216
author Fang, Chuling
Huang, Hui
Xu, Zuojun
author_facet Fang, Chuling
Huang, Hui
Xu, Zuojun
author_sort Fang, Chuling
collection PubMed
description BACKGROUND: Sarcoidosis is a granulomatous disease, the etiology of which is currently unknown. The role of mycobacteria in the etiology of sarcoidosis has been extensively investigated. In this meta-analysis, we assessed the immunological evidence of the possible role of mycobacteria in the pathogenesis and development of sarcoidosis. METHODS: We performed a systematic search of relevant articles from PubMed, Embase and Cochrane Library databases published between January 1990 and October 2015. Data extracted from the articles were analyzed with Review Manager 5.3 (Cochrane Collaboration, Oxford, UK). RESULTS: In this meta-analysis, 13 case-control studies (733 participants) were considered eligible according to our criteria. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS). The positivity incidence of the immune response (either the cell-mediated response or humoral response) in sarcoidosis patients was significantly higher than that in controls, as determined using fixed-effects model. The odds ratio (OR) of the positivity incidence of T-cell response in the patients with sarcoidosis versus the controls with PPD- or unknown PPD status was 5.54 (95% CI 3.56–8.61); the ORs were 16.70 (95% CI 8.19–34.08) and 1.48 (95% CI 0.74–2.96) for the two subgroups with PPD- controls and unknown PPD status respectively. However, the OR of the positivity incidence in patients with sarcoidosis versus PPD+ controls (latent tuberculosis infection; LTBI) was 0.26 (95% 0.10–0.66). Regarding the humoral response, pooled analysis of the positivity incidence revealed an OR (95%CI) of 20.43 (5.53–75.53) for the patients with sarcoidosis versus controls; the ORs were 11.93 (95% CI 2.15–66.27) and 41.97 (95% CI 5.24–336.15) in two subgroups of controls with PPD- and unknown PPD statuses respectively. Data on heterogeneity and evidence of publication bias were examined. CONCLUSIONS: This meta-analysis confirmed the existence of an association between mycobacteria (especially M.tuberculosis) and sarcoidosis. The current available evidence indicates that some insoluble mycobacterial antigens that preferentially within the body are involved in the pathogenesis of sarcoidosis rather than the whole mycobacteria and that they elicit a type IV immune response.
format Online
Article
Text
id pubmed-4968811
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49688112016-08-18 Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis Fang, Chuling Huang, Hui Xu, Zuojun PLoS One Research Article BACKGROUND: Sarcoidosis is a granulomatous disease, the etiology of which is currently unknown. The role of mycobacteria in the etiology of sarcoidosis has been extensively investigated. In this meta-analysis, we assessed the immunological evidence of the possible role of mycobacteria in the pathogenesis and development of sarcoidosis. METHODS: We performed a systematic search of relevant articles from PubMed, Embase and Cochrane Library databases published between January 1990 and October 2015. Data extracted from the articles were analyzed with Review Manager 5.3 (Cochrane Collaboration, Oxford, UK). RESULTS: In this meta-analysis, 13 case-control studies (733 participants) were considered eligible according to our criteria. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS). The positivity incidence of the immune response (either the cell-mediated response or humoral response) in sarcoidosis patients was significantly higher than that in controls, as determined using fixed-effects model. The odds ratio (OR) of the positivity incidence of T-cell response in the patients with sarcoidosis versus the controls with PPD- or unknown PPD status was 5.54 (95% CI 3.56–8.61); the ORs were 16.70 (95% CI 8.19–34.08) and 1.48 (95% CI 0.74–2.96) for the two subgroups with PPD- controls and unknown PPD status respectively. However, the OR of the positivity incidence in patients with sarcoidosis versus PPD+ controls (latent tuberculosis infection; LTBI) was 0.26 (95% 0.10–0.66). Regarding the humoral response, pooled analysis of the positivity incidence revealed an OR (95%CI) of 20.43 (5.53–75.53) for the patients with sarcoidosis versus controls; the ORs were 11.93 (95% CI 2.15–66.27) and 41.97 (95% CI 5.24–336.15) in two subgroups of controls with PPD- and unknown PPD statuses respectively. Data on heterogeneity and evidence of publication bias were examined. CONCLUSIONS: This meta-analysis confirmed the existence of an association between mycobacteria (especially M.tuberculosis) and sarcoidosis. The current available evidence indicates that some insoluble mycobacterial antigens that preferentially within the body are involved in the pathogenesis of sarcoidosis rather than the whole mycobacteria and that they elicit a type IV immune response. Public Library of Science 2016-08-01 /pmc/articles/PMC4968811/ /pubmed/27479700 http://dx.doi.org/10.1371/journal.pone.0154716 Text en © 2016 Fang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fang, Chuling
Huang, Hui
Xu, Zuojun
Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis
title Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis
title_full Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis
title_fullStr Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis
title_full_unstemmed Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis
title_short Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis
title_sort immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968811/
https://www.ncbi.nlm.nih.gov/pubmed/27479700
http://dx.doi.org/10.1371/journal.pone.0154716
work_keys_str_mv AT fangchuling immunologicalevidencefortheroleofmycobacteriainsarcoidosisametaanalysis
AT huanghui immunologicalevidencefortheroleofmycobacteriainsarcoidosisametaanalysis
AT xuzuojun immunologicalevidencefortheroleofmycobacteriainsarcoidosisametaanalysis